Artificial Intelligence Driven Workflow for Accelerating Design of Novel Photosensitizers
Hongyi Wang, Xiuli Zheng, Weimin Liu, Zitian Tang, Sheng Gong
TL;DR
This work addresses the slow pace of photosensitizer discovery by introducing AAPSI, an AI-driven closed-loop workflow that combines scaffold-based molecule generation, graph-transformer-based property prediction, and multi-objective Bayesian optimization. Leveraging a solvent-aware database of over 100k PS-solvent pairs, the authors generate thousands of candidates and experimentally validate top hits, notably HB4Ph with $\\phi_\\Delta$=0.85 and $\\lambda_{max}$=645 nm, placing it at the Pareto frontier for PDT-relevant properties. Key contributions include a large PS-solvent database, a scaffold-guided generative model (MoLeR), a predictive model (SolutionNet) with uncertainty quantification, and MOBO-guided generation that yields synthetically accessible, high-performance candidates. The results demonstrate that AI-guided design can rapidly identify PDT-optimized photosensitizers and provide a practical pathway toward closed-loop discovery in materials science, with a public database and synthesized molecules illustrating real-world impact.
Abstract
The discovery of high-performance photosensitizers has long been hindered by the time-consuming and resource-intensive nature of traditional trial-and-error approaches. Here, we present \textbf{A}I-\textbf{A}ccelerated \textbf{P}hoto\textbf{S}ensitizer \textbf{I}nnovation (AAPSI), a closed-loop workflow that integrates expert knowledge, scaffold-based molecule generation, and Bayesian optimization to accelerate the design of novel photosensitizers. The scaffold-driven generation in AAPSI ensures structural novelty and synthetic feasibility, while the iterative AI-experiment loop accelerates the discovery of novel photosensitizers. AAPSI leverages a curated database of 102,534 photosensitizer-solvent pairs and generate 6,148 synthetically accessible candidates. These candidates are screened via graph transformers trained to predict singlet oxygen quantum yield ($φ_Δ$) and absorption maxima ($λ_{max}$), following experimental validation. This work generates several novel candidates for photodynamic therapy (PDT), among which the hypocrellin-based candidate HB4Ph exhibits exceptional performance at the Pareto frontier of high quantum yield of singlet oxygen and long absorption maxima among current photosensitizers ($φ_Δ$=0.85, $λ_{max}$=650nm).
